Exploring the Efficacy and Safety of Siponimod in Patients With Secondary Progressive Multiple Sclerosis (EXPAND)
Clinical trial NCT01665144 · COMPLETED
Trial details
- NCT number
- NCT01665144
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-12-20
- Primary completion
- 2016-04-29
- Enrollment
- 1651
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.